Skip to main content
. 2021 May 18;61(1):24–41. doi: 10.1093/rheumatology/keab452

Table 1.

Risk of bias assessment of included studies according to the modified Newcastle-Ottawa Scale—Version for cohort studies (n = 11)

Quality assessment APS studies
SLE studies NPSLE studies
Arvanitakis et al. (2019) [20] Homayoon et al. (2014) [21] Zamproni et al. (2013) [22] Erkan et al. (2010) [23] Chapman et al. (2002) [24] Whitelaw et al. (1999) [25] Sarbu et al. (2015) [26] Steup-Beekman et al. (2013) [27] Abda et al. (2013) [28] Zirkzee et al. (2012) [29] Cantú-Brito et al. (2010) [30]
Selection
1. Is the case definition adequate
2. Representativeness of cases
3. Ascertainment of exposure
4. Outcome of interest was not present at start of study
Comparability
5. Study controls for most important factor
6. Study controls for second important factor
Outcome
7. Assessment of outcome ●● ●● ●● ●● ●● ●● ●● ●● ●●
8. Statistical test (CS only)
9. Adequate follow up period for outcome of interest (LS only)
10. Adequacy of follow up of cohorts (LS only)
Total score 9/9 9/9 6/9 7/9 4/9 5/9 9/9 5/9 6/9 5/9 6/9

CS: cross-sectional studies; LS: longitudinal studies.